Author, year | No. included in analysis (intervention/ control) | Follow-up time (Month) | No. (%) of major bleeding (intervention/ control) | No. (%) of non-fatal stroke (intervention/ control) | No. (%) of recurrent myocardial infarction (intervention/ control) |
---|---|---|---|---|---|
ADMIT [28] | 39/42 | 6 | Â | Â | 3(7.7)/3(7) |
42/46 | 1 | Â | Â | 2(4.7)/0 | |
49/51 | 0 | Â | Â | 1(2)/0 | |
Bulum 2012 [29] | 30/30 | 6 | Â | 0/0 | 0/0 |
Chao 2008 [30] | 37/37 | Â | Â | Â | Â |
De Luca 2006 [31] | 35/38 | 6 | Â | Â | 1/0 |
88/87 | 24 | Â | Â | 0/1(1.14) | |
EXPORT [34] | 120/129 | 1 | Â | Â | 2(0.016)/1(0.77) |
IMPACT [35] | 20/21 | 6 | Â | Â | Â |
222/207 | 12 | NA | 2(0.9)/3(1.4) | 1(0.45)/3(1.4) | |
218/214 | 1 | 2(0.9)/4(1.86) | 0/1(0.46) | 1(0.45)/2(0.93) | |
ITTI [38] | 52/48 | 6 | 0/0 | 1(1.92)/0(0) | 2(3.84)/5(10.41) |
Kaltoft 2006 [39] | 108/107 | 1 | Â | 2(1.85)/0(0) | 0/1(0.93) |
Liistro 2009 [40] | 55/56 | Â | Â | Â | 3(5.4)/3(5.3) |
REMEDIA [41] | 48/48 | 1 | Â | 1(2)/1(2) | 2(4)/2(4) |
Shehata 2014 [25] | 48/46 | 8 | Â | Â | 4(8)/6(13) |
Sim 2013 [42] | 43/43 | 12 | Â | Â | Â |
529/531 | 1 | 20(3.78)/18(3) | Â | 4(0.75)/10(1.88) | |
530/530 | 12 | Â | Â | 12(2.26)/23(4.3) | |
3621/3623 | 12 | Â | 19(0.52)/18(0.4)* | 96(2.7)/99(2.7) | |
3621/3623 | 1 | Â | Â | 19(0.52)/31(0.85) | |
TOTAL [6] | 5033/5030 | 6 | 79(1.5)/77(1.5) | 52(1)/25(0.5) | 99(2)/92(1.8) |
5033/5030 | 1 | Â | 33(0.65)/16(0.32) | Â | |
59/61 | 12 | NA | NA | 1(1.7)/0 | |
71/70 | 0 | NA | 0/1(1.4) | 0/0 | |
VAMPIRE [47] | 170/158 | 8 | Â | Â | 0/1(0.6) |
178/171 | 0 | Â | Â | 0/1(0.6) | |
Yin 2011 [48] | 73/91 | 12 | Â | Â | 3(4)/6(6.6) |